| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,405 | 13,301 | 9,929 | 10,102 | | Cost of Revenue | 6,349 | 6,819 | 5,069 | 4,945 | | | Gross Profit | 7,056 | 6,482 | 4,860 | 5,157 | | | Operating Expenses | | Research Development | 192 | 91 | 86 | 84 | | Selling General and Administrative | 4,118 | 3,608 | 2,481 | 2,595 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,746 | 2,783 | 2,292 | 2,477 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (29) | (109) | 5 | 16 | | Earnings Before Interest And Taxes | 2,717 | 2,675 | 2,297 | 2,493 | | Interest Expense | 20 | 20 | 21 | 27 | | Income Before Tax | 2,697 | 2,654 | 2,277 | 2,466 | | Income Tax Expense | 510 | 491 | 381 | 409 | | Minority Interest | 3 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,189 | 2,163 | 1,896 | 2,057 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,189 | 2,163 | 1,896 | 2,057 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,189 | $2,163 | $1,896 | $2,057 |
|
0.51% Nasdaq 
Income Statement
